Mark Devlin

No open positions remaining

Consumer Services

Health Technology

Government

Profile

Mark Devlin formerly worked at CTxONE, as Chief Executive Officer, Oncology One Pty Ltd., as Chief Operating Officer from 2018 to 2019, Peter MacCallum Cancer Institute, as Associate Professor from 2008 to 2019, and Amplia Therapeutics Ltd., as Chief Scientific Advisor.
Dr. Devlin received his Masters Business Admin degree from Melbourne Business School and doctorate degree from the University of Melbourne.

Former positions of Mark Devlin

Companies	Position	End
Peter MacCallum Cancer Institute Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services	Corporate Officer/Principal	31/08/2019
Oncology One Pty Ltd. Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer	Chief Operating Officer	31/08/2019
CTxONE	Chief Executive Officer	-
AMPLIA THERAPEUTICS LIMITED	Chief Tech/Sci/R&D Officer	-

See the detail of Mark Devlin's experience

Training of Mark Devlin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Devlin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Melbourne Business School Melbourne Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oncology One Pty Ltd. Oncology One Pty Ltd. BiotechnologyHealth Technology Develops novel oncology drug and clinical diseases for cancer	Health Technology
University of Melbourne University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Peter MacCallum Cancer Institute Peter MacCallum Cancer Institute General GovernmentGovernment Provides health care services	Government
Amplia Therapeutics Ltd. Amplia Therapeutics Ltd. BiotechnologyHealth Technology Develops drug candidates for oncology and chronic fibrosis	Health Technology
CTxONE

See company connections